These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
562 related articles for article (PubMed ID: 30309325)
1. Validity and prognostic significance of sperm protein 17 as a tumor biomarker for epithelial ovarian cancer: a retrospective study. Brunette LL; Mhawech-Fauceglia PY; Ji L; Skeate JG; Brand HE; Lawrenson K; Walia S; Chiriva-Internati M; Groshen S; Roman LD; Kast WM; Da Silva DM BMC Cancer; 2018 Oct; 18(1):970. PubMed ID: 30309325 [TBL] [Abstract][Full Text] [Related]
2. Clinical associations between ASCT2 and p‑mTOR in the pathogenesis and prognosis of epithelial ovarian cancer. Guo H; Xu Y; Wang F; Shen Z; Tuo X; Qian H; Wang H; Wang K Oncol Rep; 2018 Dec; 40(6):3725-3733. PubMed ID: 30272366 [TBL] [Abstract][Full Text] [Related]
3. CYR61, a potential biomarker of tumor inflammatory response in epithelial ovarian cancer microenvironment of tumor progress. Shi J; Huo R; Li N; Li H; Zhai T; Li H; Shen B; Ye J; Fu R; Di W BMC Cancer; 2019 Nov; 19(1):1140. PubMed ID: 31766991 [TBL] [Abstract][Full Text] [Related]
4. Expression of glucose transporter protein 1 and p63 in serous ovarian tumor. Cai Y; Zhai JJ; Feng BB; Duan XZ; He XJ J Obstet Gynaecol Res; 2014 Jul; 40(7):1925-30. PubMed ID: 25056472 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Increased Expression of Annexin A10 (ANXA10) in Serous Epithelial Ovarian Cancer. Wang J; Zhao S; Wang F; Wang J; Zhang Y Med Sci Monit; 2019 Jul; 25():5666-5673. PubMed ID: 31363077 [TBL] [Abstract][Full Text] [Related]
6. [Expression and significance of PD-1 and PD-L1 in the specimens of epithelial ovarian cancer]. Ju C; Gao JC; Zhang PX; Zhang KN; Yang S; Kang TJ; Zhao HZ; Qi WJ; Zhang QP; Kong FD; Guan HW; Shi H Zhonghua Fu Chan Ke Za Zhi; 2020 Aug; 55(8):529-534. PubMed ID: 32854477 [No Abstract] [Full Text] [Related]
7. Quantitative analysis of follicle-stimulating hormone receptor in ovarian epithelial tumors: a novel approach to explain the field effect of ovarian cancer development in secondary mullerian systems. Wang J; Lin L; Parkash V; Schwartz PE; Lauchlan SC; Zheng W Int J Cancer; 2003 Jan; 103(3):328-34. PubMed ID: 12471615 [TBL] [Abstract][Full Text] [Related]
8. [Expression and promotor methylation of p73 gene in ovarian epithelial tumors]. Zhang YL; Guo XR; Shen DH; Cheng YX; Liang XD; Chen YX; Wang Y Zhonghua Bing Li Xue Za Zhi; 2012 Jan; 41(1):33-8. PubMed ID: 22455848 [TBL] [Abstract][Full Text] [Related]
9. MDM2 Expression in Serous and Mucinous Epithelial Tumours of the Ovary. Abdelaal SE; Habib FM; El Din AA; Gabal SM; Hassan NS; Ibrahim NA Asian Pac J Cancer Prev; 2016; 17(7):3295-300. PubMed ID: 27509966 [TBL] [Abstract][Full Text] [Related]
10. Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer. Harmankaya İ; Akar S; Uğraş S; Güler AH; Ezveci H; Aydoğdu M; Çelik Ç J Obstet Gynaecol; 2021 Feb; 41(2):248-253. PubMed ID: 32285726 [TBL] [Abstract][Full Text] [Related]
11. Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer. Han GH; Chay DB; Nam S; Cho H; Chung JY; Kim JH BMC Cancer; 2019 Dec; 19(1):1202. PubMed ID: 31823759 [TBL] [Abstract][Full Text] [Related]
12. [Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma]. Sun LX; Wu Y; Han HQ; Wang QH Ai Zheng; 2003 Jan; 22(1):58-61. PubMed ID: 12561438 [TBL] [Abstract][Full Text] [Related]
13. Alpha(v)beta(6) integrin-A marker for the malignant potential of epithelial ovarian cancer. Ahmed N; Riley C; Rice GE; Quinn MA; Baker MS J Histochem Cytochem; 2002 Oct; 50(10):1371-80. PubMed ID: 12364570 [TBL] [Abstract][Full Text] [Related]
14. Engrailed-2 (EN2) - a novel biomarker in epithelial ovarian cancer. McGrath SE; Annels N; Madhuri TK; Tailor A; Butler-Manuel SA; Morgan R; Pandha H; Michael A BMC Cancer; 2018 Oct; 18(1):943. PubMed ID: 30285763 [TBL] [Abstract][Full Text] [Related]
15. Expression of Placenta Growth Factor Is Associated with Unfavorable Prognosis of Advanced-Stage Serous Ovarian Cancer. Meng Q; Duan P; Li L; Miao Y Tohoku J Exp Med; 2018 Apr; 244(4):291-296. PubMed ID: 29643276 [TBL] [Abstract][Full Text] [Related]
16. Stage-specific embryonic antigen 4 expression in epithelial ovarian carcinoma. Ye F; Li Y; Hu Y; Zhou C; Hu Y; Chen H Int J Gynecol Cancer; 2010 Aug; 20(6):958-64. PubMed ID: 20683402 [TBL] [Abstract][Full Text] [Related]
17. Significance of cell cycle regulatory proteins as malignant and prognostic biomarkers in ovarian epithelial tumors. Lee YH; Heo JH; Kim TH; Kang H; Kim G; Kim J; Cho SH; An HJ Int J Gynecol Pathol; 2011 May; 30(3):205-17. PubMed ID: 21464733 [TBL] [Abstract][Full Text] [Related]
18. Mortalin is a distinct bio-marker and prognostic factor in serous ovarian carcinoma. Xu M; Jin T; Chen L; Zhang X; Zhu G; Wang Q; Lin Z Gene; 2019 May; 696():63-71. PubMed ID: 30776464 [TBL] [Abstract][Full Text] [Related]
19. The role and prognostic value of inducible nitric oxide synthase (iNOS) and interleukin-33 (IL-33) in serous and mucinous epithelial ovarian tumours. Saied EM; El-Etreby NM Ann Diagn Pathol; 2017 Apr; 27():62-68. PubMed ID: 28325363 [TBL] [Abstract][Full Text] [Related]
20. High expression of TRIM24 predicts worse prognosis and promotes proliferation and metastasis of epithelial ovarian cancer. Zhang L; Chen H; Ding B; Jiang W J Ovarian Res; 2022 Feb; 15(1):19. PubMed ID: 35105347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]